Murtuza Bharmal, PhD, MS
EMD Serono Research & Development Institute, Inc., Rockland, MA, USA; a business of Merck KGaA, Darmstadt, Germany
Murtuza Bharmal, PhD, MS, B.Pharm. is a globally experienced leader having held senior positions within multinational biopharmaceutical and consulting environments with over 20 years’ experience within R&D and Commercial organizations. Murtuza has lived and worked in the US, Germany, China and India with an appreciation of cross-cultural leadership. Demonstrating his expertise in using scientific tools to inform decision making at various levels in healthcare, Murtuza has authored over 150 original research articles and presentations in a variety of international journals and professional conferences. Some of the projects Murtuza has led have also had a fundamental effect on the wider use of Health Economics and Outcomes Research (HEOR) including the development of a new PRO instrument (TSQM-9), the development of Assessment Schedule Matching (ASM) to improve indirect treatment comparisons as well as leadership of the ‘Merkel Cell Carcinoma (MCC) Observational Study’ which was awarded “Best in HEOR” at the CARE Awards 2018. Testimony to his thought leadership in the field of outcomes research, Murtuza was appointed as co-editor of a leading international journal Value & Outcomes Spotlight.
Editorial Board
Terms of Appointment: September 2023 - August 2025